Research brings hope for the future
“All the promising research makes you feel like there is light at the end of that very dark tunnel after all.”
Search results
“All the promising research makes you feel like there is light at the end of that very dark tunnel after all.”
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
Biotechnology company ProQR has announced encouraging results from its early analysis of the phase 1/2 trial of QR-421a, an innovative approach to treating sight loss caused by mutations in a particular section of the USH2A gene.